SaaS entity

ADMA Biologics, Inc.

Company ADMA

Every one of those 1 sits in a single category, earnings. Of the tracked stories, 1 of 1 also mention ASCENIV, the most common co-covered peer. Source depth averages 4 original sources per story, versus 3.1 across the same-window beat baseline.

Last mentioned: Jul 12, 2026

RSS updates
Share

Entity pulse

Recent coverage · ADMA Biologics, Inc.

1 story
7 avg impact
0% positive
100% negative

Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.

  • 100% negative

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about ADMA Biologics, Inc.

Every one of those 1 sits in a single category, earnings. Of the tracked stories, 1 of 1 also mention ASCENIV, the most common co-covered peer. Source depth averages 4 original sources per story, versus 3.1 across the same-window beat baseline. Their average consequence score of 7 runs below the beat's 7.1 for that window. ADMA Biologics, Inc. appears in 1 tracked SaaS story from July 12, 2026.

Stories tracked
1
Sources per story
4

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 20 SaaS stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering ADMA Biologics, Inc.. Shared-story counts are live from our verified record — not editorial picks.

Stories mentioning ADMA Biologics, Inc. 1

ADMA Biologics, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.